Cipla share will remain in focus on Thursday ... Afrezza is a rapid-acting insulin delivered through an inhaler as compared to current insulins which are given as injections.
It has also notified extension of separate ceiling price of IV fluids in special packaging and separate ceiling price for Cipla's Synchrobreathe inhaler, following a latest Authority meeting. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback